Cargando…

Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico

BACKGROUND: In resource-constrained settings, data regarding breast cancer patients' adherence to endocrine therapy (ET) and physicians’ prescribing practices is limited. This study aims to decrease this knowledge gap in a real-world clinical practice. METHODS: Premenopausal women with stage 0-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villarreal-Garza, Cynthia, Mesa-Chavez, Fernanda, Ferrigno, Ana S., De la Garza-Ramos, Cynthia, Fonseca, Alan, Villanueva-Tamez, Karen, Campos-Salgado, Jose Y., Cruz-Ramos, Marlid, Rodriguez-Gomez, David O., Ruiz-Cruz, Sandy, Cabrera-Galeana, Paula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192863/ https://www.ncbi.nlm.nih.gov/pubmed/34116366 http://dx.doi.org/10.1016/j.breast.2021.05.013

Ejemplares similares

Clinical utility of genomic signatures in young breast cancer patients: a systematic review
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2020)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
por: Lambertini, Matteo, et al.
Publicado: (2019)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

The challenges of breast cancer care in Mexico during health-care reforms and COVID-19
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis
por: Becerril-Gaitan, Andrea, et al.
Publicado: (2022)

Extended adjuvant endocrine treatment for premenopausal women: A Delphi approach to guide clinical practice
por: Buono, Giuseppe, et al.
Publicado: (2022)

Impact of Delayed Adjuvant Radiotherapy in the Survival of Women with Breast Cancer
por: Flores-Balcázar, Christian H, et al.
Publicado: (2018)

Health belief about adjuvant endocrine therapy in premenopausal breast cancer survivors: a qualitative study
por: Xu, Lei, et al.
Publicado: (2019)

Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2020)

An overview of resistance to chemotherapy in osteosarcoma and future perspectives
por: Garcia-Ortega, Dorian Yarih, et al.
Publicado: (2022)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project
por: Pelizzari, Giacomo, et al.
Publicado: (2018)

Machine Learning for Opportunistic Screening for Osteoporosis from CT Scans of the Wrist and Forearm
por: Sebro, Ronnie, et al.
Publicado: (2022)

Correction: Sebro, R.; De la Garza-Ramos, C. Machine Learning for Opportunistic Screening for Osteoporosis from CT Scans of the Wrist and Forearm. Diagnostics 2022, 12, 691
por: Sebro, Ronnie, et al.
Publicado: (2022)

Support vector machines are superior to principal components analysis for selecting the optimal bones’ CT attenuations for opportunistic screening for osteoporosis using CT scans of the foot or ankle
por: Sebro, Ronnie, et al.
Publicado: (2022)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases
por: MADEDDU, CLELIA, et al.
Publicado: (2014)

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
por: Pagani, Olivia, et al.
Publicado: (2020)

Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
por: Gössling, Gustavo, et al.
Publicado: (2023)

Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study
por: Barrios, Carlos, et al.
Publicado: (2022)

Adherence to Adjuvant Tamoxifen in Mexican Young Women with Breast Cancer
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2021)

Adjuvant hormonal therapy in premenopausal women with breast cancer
por: Smyth, Lillian, et al.
Publicado: (2015)

Breast Cancer Diagnostic Delays Among Young Mexican Women Are Associated With a Lack of Suspicion by Health Care Providers at First Presentation
por: Unger-Saldaña, Karla, et al.
Publicado: (2019)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Hormonal Replacement Therapy in Premenopausal Women With Hypogonadism: An Analysis of Prescriber Practices
por: Martirossian, Alexandra Nicole, et al.
Publicado: (2021)

Young Women with Breast Cancer in Resource-Limited Settings: What We Know and What We Need to Do Better
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2021)

Activities Performed by ASCO-Sponsored Oncology Student Interest Groups in Latin America: Assessing Members' Preferences and Leaders' Challenges
por: Núñez-Peña, Emilia, et al.
Publicado: (2022)

Gaps in Knowledge and Understanding of Patients With Metastatic Breast Cancer in Mexico
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2020)

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
por: Forward, D P, et al.
Publicado: (2004)

Effect of receiving a customizable brochure on breast cancer patients' knowledge about their diagnosis and treatment: A randomized clinical trial
por: Villarreal‐Garza, Cynthia, et al.
Publicado: (2023)

Myocardial Infarction in a Premenopausal Woman on Leuprolide Therapy
por: Perez, Irving E., et al.
Publicado: (2015)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection
por: Espinosa-Ramos, David, et al.
Publicado: (2019)

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.
por: Bruning, P. F., et al.
Publicado: (1990)

Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer
por: Lee, Young-Won, et al.
Publicado: (2023)

A dose-comparative endocrine-clinical study of leuprorelin in premenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1990)

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer
por: Brett, Jo, et al.
Publicado: (2018)

Letter to Editor, Re: The first report on Covid-19 vaccine refusal by cancer patients in Italy: Early data from a single-institute survey: Educational Webinar about COVID-19 Vaccines in Oncological Patients: A Promising Strategy to Tackle COVID-19 Vaccine Hesitancy
por: Villarreal-Garza, Cynthia, et al.
Publicado: (2021)

Biomarkers of mammographic density in premenopausal women
por: His, Mathilde, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oml1qi8i0n7sl5i0up48h3pn55